Introduction
Bile acids (BAs), accounting approximately for 50 -70% of total bile solid, are the primary components of human and animal biles. These organic acids were synthesized in liver from cholesterol, and formed taurine-and glycine-conjugates via the amidation on carbon 24 to participate into the enterohepatic circulation. 1 Previous studies have shown that BAs are important for lipid and fat-soluble vitamin absorption, cholesterol homeostasis, intestinal signaling, and possess a therapeutical effect in treating cholesterol gallstones and cholestatic liver diseases. [2] [3] [4] [5] For a healthy person, approximately 2/5 of synthesized cholesterol is converted into bile acid in the liver, of which, up to 5 percent passed out of the body along with the faeces. 1, 6 That means that the waste of other animals may contain bile acids, and that the structures and contents may vary from animals to animals, so it is well worth to investigate the bile acids in the corresponding traditional medicines.
Hei-Bing-Pian and Trogopterus Dung are the discharges of wild boar and Trogopterus xanthipes, respectively. They are two kinds of commonly used clinical animal waste medication in traditional medicine.
Hei-Bing-Pian is an important traditional Mongolian medicine for digestion aid, anti-virus, clearing heat, and detoxicating. It is frequently combined with other traditional medicines in the clinic to treat bilious fever, cholelithiasis, jaundice, viral fever, etc. 7, 8 Trogopterus Dung (Faeces Trogopterori) is a traditional Chinese medicine used to promote blood circulation, to remove blood stasis to stop bleeding, and to eliminate toxin. In clinics, Trogopterus Dung is often used in medical prescriptions to treat the pain of heart blood stasis, amenorrhea, postpartum pain, uterine bleeding, etc.
9,10
Numbers of analytical methods have been developed for the separation and quantification of bile acids in related drugs using high-performance liquid chromatography (HPLC)/gas chromatography (GC) coupled with mass spectrometry, or an evaporative light-scattering detector (ELSD). [11] [12] [13] [14] These methods have played important roles in the differentiation and identification of bile acids, and have provided valuable data for scientific research and clinical use. However, due to the similar structures, same molecular weights of analogous, similar fragmentation path ways, the presence of isomeric forms and the similar physicochemical properties, it is hard to simultaneously analyze multiple bile acids simply, sensitively, directly, and validly within a short time. Ultra-high-performance liquid chromatograph-triple quadrupole mass spectrometry (UHPLC-QQQMS) can significantly improve the resolution, shorten the analysis time, produce high sensitivity, and individually quantify compounds of same retention times so long as they have different precursor or product ions by An ultra-high-performance liquid chromatograph-triple quadrupole mass spectrometry has been established and validated for the simultaneous quantification of 15 bile acids in four traditional animal medicines and their preparations. The separations of bile acids were performed on an Agilent ZORBAX Eclipse XDB-C18 column (50 × 2.1 mm; 1.8 μm) with methanol-0.1% formic acid as the mobile phase. Glycyrrhetinic acid was added as internal standard owing to its similar physiochemical properties with the bile acids. Using this condition, detected in the multiple reaction monitoring mode, the 15 bile acids, including three groups of isomers, were well quantified individually. Method validation showed that the linear regression relationship (r 2 employing an multiple reaction monitoring mode (MRM). 15, 16 In this study, we established and validated a rapid and sensitive method using UHPLC-QQQMS in the MRM mode to simultaneously determine 15 bile acids in biosamples. The established method was applied to quantify bile acids in two bile-based medicines (bear bile and bezoar (Niu Huang)), two animal waste-based medicines (Hei-Bing-Pian and Trogopterus Dung), and three traditional medicine preparations containing these animal medicines.
Experimental

Chemicals, materials and equipments
Methanol, formic acid and water of HPLC-grade were purchased from Fisher Scientific (Fair Lawn, NJ, USA), Alfa Aesar (Heysham, Lancs, UK) and Watson's Food beverage Co. (Guangzhou, Guangdong, China), respectively. Dimethyl sulfoxide (DMSO) was purchased from Biosharp (Hefei, Anhui, China). Syringe filters (0.22 μm membrane) were purchased from Xiboshi (Tianjin, China). The 15 bile acids standards with purity ≥98% (determined by HPLC) were provided by Prof. Xiu-Hong Wu (Heilongjiang University of Chinese Medicine). These bile acids and their abbreviations were: cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), ursodeoxycholic acid (UDCA), taurocholic acid (TCA), taurochenodeoxycholic acid (TCDCA), 7-keto-taurochenodeoxycholic acid (7-keto-TCDCA), taurodeoxycholic acid (TDCA), taurolithocholic acid (TLCA), tauroursodeoxycholic acid (TUDCA), glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), glycodeoxycholic acid (GDCA), glycolithocholic acid (GLCA) (Fig. 1) . The internalstandard glycyrrhetinic acid (GA) was from Yoneyama Yakuhin Kogyo Co., Ltd. (Osaka, Japan). Crude and baked Hei-BingPian samples were provided by College of Mongolian medicine, Inner Mongolia Medical University. Trogopterus Dung, bear bile and bezoar were purchased from JingYuan drug store (Huhhot, Inner Mongolia, China); Alatan-aru-5 watered pills (containing Hei-Bing-Pian and Trogopterus Dung) and Bear bile capsules (containing bear bile) were purchased from Fu Rui drug store (Huhhot, Inner Mongolia, China); Angongniuhuang honeyed pills (containing Bezoar) was bought from Tong Yi drug store (Huhhot, Inner Mongolia, China). An Agilent 1290 ultra-high-performance liquid chromatography coupled with a 6430 triple quadrupole mass spectrometer with an ESI ion source was used (Agilent Technologies Singapore (International) Pte. Ltd., Singapore). High-purity nitrogen gas was generated with a PEAK BN32LA instrument (PEAK Scientific Instruments Ltd., Glasgow, UK). Gradient chromatographic separation was performed on an Agilent ZORBAX Eclipse XDB-C18 column (50 × 2.1 mm; 1.8 μm).
Preparation of standard solutions
The bile acids and internal standard were dissolved separately in DMSO to prepare stock solutions at 10 mg/mL. The internalstandard solution was further diluted with DMSO to a concentration of 1 mg/mL. To 410 μL of DMSO were added 5 μL of each stock solution of the 15 bile acids and 15 μL of the 1 mg/mL internal standard solution to form a solution containing 100 μg/mL of each standard compound and 30 μg/mL of internal standard. This solution was diluted with DMSO containing 30 μg/mL of the internal standard in the ratio of 1:3:3:3:3:3:3:3:3 to form a series of calibration solutions at nine levels. The concentrations of the internal standard was kept constant (30 μg/mL) in all calibration and sample solutions.
Sample preparation
The samples were pulverized with an all-powerful pulverizer QE-100 g (Yili Industry and Trade Co., Ltd., Zhejiang, China) into fine powder. An aliquot of 100 mg of each sample was dissolved, respectively, in methanol containing an internal standard (IS-MeOH) at a solid-liquid ratio of 100 mg:4 mL. The mixture was centrifuged at 5000 rpm for 1.5 min after ultrasonication for 20 min. The supernatants were filtered through 0.22 μm membranes and diluted with IS-MeOH into appropriate concentrations to meet the calibration range before quantitative analysis.
Validation method
The method was validated by referring to the ICH Q2 (R1) guidelines 17 and a recognized validation method. 16 Linear correlations were established by using the ratios of the peakareas of bile acids to the internal standard as the Y axis and the concentrations of the bile acids as the X axis. LOD and LQD were defined as the concentrations at which the signal-to-noise ratios were 3 and 10, respectively. The precision of the method was measured by testing the standard solutions at low, middle, and high concentration levels 5 times per day (intra-day precision) consecutively for 3 days (inter-day precision). Measurements of the method accuracies (expressed as the recoveries) were conducted by adding standard solutions at three known concentration levels into samples of known analyte concentrations and underwent the same sample preparation and quantification procedures. The recoveries were calculated by the formula: recovery (%) = 100 × actual concentration/ theoretical concentration.
Results and Discussion
Optimized LC-MS conditions
Separations of the bile acids were performed on an Agilent ZORBAX Eclipse XDB-C18 column (50 × 2.1 mm; 1.8 μm) with different ratios of the mobile phases that were composed of 0.1% formic acid and MeOH as solvents A and B at a flow rate of 0.4 mL/min. The optimized linear-gradient elution program was varied as follows: 0 -6 min, 55% B; 6.1 -8 min, 58 -69% B; 8 -15 min, 69% B; 15 -16 min, 69 -100% B; 16 -18 min, 100% B. The column temperature was 30 C and the injection volume was 2 μL.
The MS detections were performed on a 6430 triple quadrupole mass spectrometer under a negative electrospray ionization source (ESI). High-purity nitrogen was used as the drying gas with a flow rate of 11 L/min, temperature of 350 C, and capillary voltage of 3500 V. A selected ion monitoring mode and a product ion scan mode were used to optimize the fragmentor, collision energy (V) and precursor/daughter ions of the bile acids. Detailed optimized data are listed in Table 1 . All of the taurine-and glycine-conjugated bile acids displayed characteristic product ions at m/z 80 and 74, corresponding to the taurine and glycine group, respectively, making these fragments useful for identifying taurine-and glycine-conjugated bile acids.
In their UHPLC profiles, groups of isomers, such as CDCA/ DCA/UDCA, TCDCA/TDCA/TUDCA, and GCDCA/GDCA, whose structures differed only at the position or orientation of a hydroxyl group, were well-separated (Fig. 2) . On the other hand, compounds of different molecular weights, such as CA/ TDCA/GCDCA and GA/LCA, partly overlapped. Using the multiple reaction monitoring mode to detect the specific precursor-product ion of each compound, these overlapped compounds were well-quantified individually.
Linearity and detection limit
Calibration standards diluted at nine levels were individually injected into UHPLC-QQQMS. By analyzing the linearity of the method using Agilent MassHunter Quantitative Analysis B.04.00 software, we could see that the linear relationship of each bile acid was satisfactory with the regression coefficients (R 2 ) being > 0.9993. The LOQs for most of the free bile acids were 0.0457 μg/mL. Conjugation with taurine or glycine increased the acidity and enhanced the sensitivity in negative mode ESI detection, as demonstrated by the even lower LOQs (0.0152 μg/mL) for most of the taurine-or glycine-conjugates ( Table 2 ). The present method with UHPLC to produce sharper peaks was more sensitive than a previously reported HPLC-MS method.
As shown in Table 3 , the relative standard deviations (RSDs) of intra-day and inter-day were 0.96 -4.31% and 1.73 -4.43%, respectively, and the recoveries of the 15 bile acids were found to range from 95.3 to 120.9%, indicating that the method is suitable for the quantification of these bile acids.
Bile acids in sample
Fine powders of crude drugs and traditional medicine preparations were extracted with methanol containing an internal standard, and the filtered extract solutions were injected into UHPLC-QQQMS using the established and validated method. The sample-preparation process was simpler than the GC-MS method, 18 which needed a derivatiation process. The whole analysis procedure was accomplished in 18 min, a short For each compound, a selected ion monitoring scan was carried out to discover the optimized fragmentor voltage, and a product ion scan was carried out to generate the optimized collision energy.
time with respect to the number of compounds analyzed and groups of isomers that existed. Compound-specific parameters, including at least two MRM transitions, the fragmentor voltage, and the collision energy were found and optimized for each bile acid so as to ensure both the specificity and the sensitivity. After processing the data with Agilent MassHunter Quantitative Analysis B.04.00 software, the bile acid concentrations were calculated by multiplying the dilution factors according to the sample preparation. The results are listed in Table 4 . All of free bile acids and the taurine-conjugated ones were found in artificial bear bile with TCA being in the highest concentration (8.55 μg/mg), while natural bear bile contained a smaller number and lower levels of bile acids. Very high levels (> 9.88 μg/mg) of CA, CDCA, DCA, UDCA, TCDCA, and TDCA were found in artificial Bezoar, while only a few bile acids in low levels were found in natural Bezoar. Most of the bile acids were also found in their formulated preparations, bear bile pills, and Angongniuhuang pill. However, at low levels, several bile acids were detected in Hei-Bing-Pian and Trogopterus Dung for the first time, and also in Alatan-aru-5 (ALT), which is a clinically used traditional Mongolian medicine made of Hei-Bing-Pian, Trogopterus Dung and three herbal medicines. These data indicated that bile acids are constituents of bile-or animal waste-based traditional medicines. However, the contents of bile acids greatly varied in the related medicines from commercial sources, also, artificial Bezoars may contain higher levels of bile acids than natural ones. As natural Bezoars are known to have better therapeutic efficacy, the bioactive constituents of other structural types may also play important roles in the therapeutic efficacy of Bezoars. Qualitative and quantitative analyze of multiple bioactive constituents are essential to guarantee the efficacy of these traditional medicines.
The presently established method could be used in combination with other analysis methods for other types of bioactive compounds for monitoring the quality of related traditional medicines and their preparations.
Conclusions
A MRM method was established to simultaneously quantify 15 bile acids including 3 groups of isomers by UHPLC-QQQMS. The linearity of the calibration curves, the precisions and the recovery were satisfactory. The whole procedure with the aid of UHPLC was completed in 18 min, shorter than the reported HPLC-MS methods. Using the established method, bile acids were quantified in four bile-or animal waste-based crude drugs and their preparations. For the first time, three bile acids (CA, TCA, and UDCA) were detected and quantified in Hei-BingPian and five (CA, TCA, LCA, DCA, and UDCA) in Trogopterus Dung. UDCA has been widely used for the treatment of cholestatic liver disease as well as gallstone dissolution and prevention, which agreed with the clinical uses of Hei-BingPian and Trogopterus Dung for liver diseases. The established method could be used for the quantification of other bile or animal waste-based crude drugs and their formulated products.
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